Getagraph.com logo
S&P 500
(0.38%) 5 207.20 points
Dow Jones
(0.47%) 39 242 points
Nasdaq
(0.25%) 16 343 points
Oil
(0.57%) $79.44
Gas
(4.80%) $2.29
Gold
(0.72%) $2 339.10
Silver
(2.93%) $28.41
Platinum
(0.66%) $991.05
USD/EUR
(-0.30%) $0.927
USD/NOK
(-0.27%) $10.86
USD/GBP
(-0.17%) $0.799
USD/RUB
(0.82%) $92.49

Aktualne aktualizacje dla Indaptus Therapeutics, [INDP]

Giełda: NASDAQ Capital Market Sektor: Healthcare Branża: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-09)

Expected move: +/- 0.00%

Ostatnio aktualizowano9 geg. 2024 @ 17:43
25% discount on Stockinvest.us - Use code: Podcast

-0.29% $ 2.07

Live Chart Being Loaded With Signals

Commentary (9 geg. 2024 @ 17:43):

Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial...

Stats
Dzisiejszy wolumen 1 351.00
Średni wolumen 90 147.00
Kapitalizacja rynkowa 17.71M
EPS $0 ( 2024-05-03 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.130
ATR14 $0.0370 (1.78%)
Insider Trading
Date Person Action Amount type
2024-01-22 Linscott Walt Addison Buy 75 000 Stock Option (Right to Buy)
2024-01-22 Waltzman Roger J. Buy 75 000 Stock Option (Right to Buy)
2024-01-22 Sassi Nir Buy 40 000 Stock Option (Right to Buy)
2024-01-22 Meckler Jeffrey A Buy 100 000 Stock Option (Right to Buy)
2024-01-22 Newman Michael James Buy 43 250 Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 90 transactions
Buy: 2 551 706 | Sell: 72 874

Indaptus Therapeutics, Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Indaptus Therapeutics, Finanse

Annual 2023
Przychody: $0
Zysk brutto: $-1 284.00 (0.00 %)
EPS: $-1.840
FY 2023
Przychody: $0
Zysk brutto: $-1 284.00 (0.00 %)
EPS: $-1.840
FY 2022
Przychody: $0
Zysk brutto: $-1 781.00 (0.00 %)
EPS: $-1.660
FY 2021
Przychody: $0.00
Zysk brutto: $0.00 (0.00 %)
EPS: $-1.890

Financial Reports:

No articles found.

Indaptus Therapeutics,

Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej